Your browser doesn't support javascript.
loading
Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study.
Leal, Ticiana; Kotecha, Rupesh; Ramlau, Rodryg; Zhang, Li; Milanowski, Janusz; Cobo, Manuel; Roubec, Jaromir; Petruzelka, Lubos; Havel, Libor; Kalmadi, Sujith; Ward, Jeffrey; Andric, Zoran; Berghmans, Thierry; Gerber, David E; Kloecker, Goetz; Panikkar, Rajiv; Aerts, Joachim; Delmonte, Angelo; Pless, Miklos; Greil, Richard; Rolfo, Christian; Akerley, Wallace; Eaton, Michael; Iqbal, Mussawar; Langer, Corey.
Affiliation
  • Leal T; Winship Cancer Institute at Emory University, Atlanta, GA, USA. Electronic address: ticiana.a.leal@emory.edu.
  • Kotecha R; Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA.
  • Ramlau R; Poznan University of Medical Sciences, Poznan, Poland.
  • Zhang L; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center (SYSUCC), Guangzhou, China.
  • Milanowski J; Medical University of Lublin, Lublin, Poland.
  • Cobo M; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain.
  • Roubec J; Nemocnice AGEL Ostrava-Vítkovice, Ostrava, Czech Republic.
  • Petruzelka L; General University Hospital in Prague, Prague, Czech Republic.
  • Havel L; Thomayer Hospital, Prague, Czech Republic.
  • Kalmadi S; Ironwood Cancer & Research Centers, Chandler, AZ, USA.
  • Ward J; Washington University School of Medicine, St Louis, MO, USA.
  • Andric Z; University Clinical Hospital Centre Bezanijska Kosa, Belgrade, Serbia.
  • Berghmans T; Jules Bordet Institute, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
  • Gerber DE; Harold C Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Kloecker G; University of Louisville, Louisville, KY, USA.
  • Panikkar R; Geisinger Cancer Institute, Danville, PA, USA.
  • Aerts J; Department of Pulmonary Medicine, The Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands.
  • Delmonte A; IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori (IRST), Meldola, Italy.
  • Pless M; Kantonsspital Winterthur, Winterthur, Switzerland.
  • Greil R; Salzburg Cancer Research Institute-Center for Clinical Cancer and Immunology Trials (SCRI-CCCIT), Salzburg, Austria; Paracelsus Medical University Salzburg, Salzburg, Austria; Cancer Cluster, Salzburg, Austria.
  • Rolfo C; Center for Thoracic Oncology, Tisch Cancer Institute at Icahn School of Medicine, Mount Sinai, New York, NY, USA.
  • Akerley W; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Eaton M; St Francis Hospital, Indianapolis, IN, USA.
  • Iqbal M; College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
  • Langer C; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Lancet Oncol ; 24(9): 1002-1017, 2023 09.
Article in En | MEDLINE | ID: mdl-37657460
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2023 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2023 Type: Article